Yahoo
Shenzhen - Delayed Quote CNY

Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ)

69.69 -1.64 (-2.30%)
At close: October 30 at 3:04:24 PM GMT+8
Chart Range Bar
Loading chart for 000661.SZ
  • Previous Close 71.33
  • Open 68.49
  • Bid 69.75 x --
  • Ask 69.79 x --
  • Day's Range 69.36 - 72.64
  • 52 Week Range 61.09 - 114.70
  • Volume 5,803,370
  • Avg. Volume 6,615,113
  • Market Cap (intraday) 28.429B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.85
  • Earnings Date --
  • Forward Dividend & Yield 0.16 (0.22%)
  • Ex-Dividend Date May 25, 2026
  • 1y Target Est 102.77

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was founded in 1993 and is based in Changchun, China.

ccht.jl.cn

10,080

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000661.SZ
24.55%
SSE Composite Index (000001.SS)
9.32%

1-Year Return

000661.SZ
39.38%
SSE Composite Index (000001.SS)
9.73%

3-Year Return

000661.SZ
51.94%
SSE Composite Index (000001.SS)
19.11%

5-Year Return

000661.SZ
72.47%
SSE Composite Index (000001.SS)
1.46%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings 275.74M
Profit Margin 0.00%

Q1

FY24

Q2

FY24

Q3

FY24

Q1

FY26

0
1B
2B
3B
0.0%

Analyst Insights

View More

Analyst Price Targets

102.77
102.77 Average
69.69 Current
102.77 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.20%

  • Return on Assets (ttm)

    0.49%

  • Return on Equity (ttm)

    -2.03%

  • Revenue (ttm)

    11.02B

  • Net Income Avi to Common (ttm)

    -352.58M

  • Diluted EPS (ttm)

    -0.85

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.88B

  • Total Debt/Equity (mrq)

    9.06%

  • Levered Free Cash Flow (ttm)

    -1.79B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: